Shepherd Therapeutics
Manufacturing · Tennessee, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1033 Demonbreun St Ste 300, Nashville, T...Phone Number
(615) 490-8597Website
shepherd.bioRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Shepherd Therapeutics
Khora Therapeutics is focused on revolutionizing global access to next-generation oncology therapeutics through advanced precision medicine. The company aims to lead in the development of innovative cancer treatments. Their mission centers on providing groundbreaking therapies to patients in need. Khora Therapeutics targets healthcare providers and institutions involved in oncology care.Explore more
Shepherd Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Shepherd Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Shepherd Therapeutics recently announced quarterly report
Shepherd Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Shepherd Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Shepherd Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Shepherd Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Shepherd Therapeutics
Product Launch: Get notified when Shepherd Therapeutics launches new products
Check out if Shepherd Therapeutics is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Shepherd Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Shepherd Therapeutics
Compare insights from companies similar to Shepherd Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Shepherd Therapeutics
<$5M
11-50
Private
<$5M
2016
LK
Liam KillingstadDirector, Investors Relations & Capital Formation
Company Profile Activity
Activity Insights
Shepherd Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Shepherd Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Shepherd Therapeutics.
Shepherd Therapeutics financials insights
Gather financial insights about Shepherd Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Shepherd Therapeutics Tech Stack
A closer look at the technologies used by Shepherd Therapeutics
Shepherd Therapeutics News & Media
SHEPHERD Therapeutics and Mayo Clinic Announce Collaboration to Advance Research in Rhabdomyosarcoma Using SHEPHERD's Precision-Oncology Platform, DELVE
BOSTON, Feb. 25, 2021 /PRNewswire/ -- SHEPHERD Therapeutics, a company dedicated to catalyzing lifesaving treatments for rare cancer patients, today announced a collaboration with the Mayo Clinic to advance research in rhabdomyosarcoma (RMS), a rare pediatric cancer with few treatment...SHEPHERD Therapeutics Announces Research Collaboration with National Institutes of Health's (NIH) National Center for Advancing Translational Sciences (NCATS) in Adenoid Cystic Carcinoma (ACC)
BOSTON, Feb. 22, 2021 /PRNewswire/ -- SHEPHERD Therapeutics, a company dedicated to catalyzing lifesaving treatments for rare cancer patients, today announced a collaboration with the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health...SHEPHERD Therapeutics and Oncoheroes Biosciences to Partner for the Discovery, Development and Commercialization of Oncology Therapeutics For Rare Cancers
BOSTON, Feb. 15, 2021 /PRNewswire/ -- SHEPHERD Therapeutics, a company dedicated to catalyzing lifesaving treatments for rare cancer patients, and Oncoheroes Biosciences, a biotech company focused on advancing new therapies for childhood cancer, today announced they have entered into a...SHEPHERD Names Dr. Catharine Young Executive Director of the SHEPHERD Foundation
WASHINGTON--(BUSINESS WIRE)--SHEPHERD and its founder David Hysong today announced it has named Catharine Young, Ph.D., as the Executive Director of the SHEPHERD Foundation. SHEPHERD was founded to fill the gaps facing the rare cancer system, and to place the focus back on the patient. SHEPHERD Therapeutics’ mission is to discover, develop and connect lifesaving cures for rare cancer patients with technology that could save millions of lives. The SHEPHERD Foundation aims to challenge the cancer
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Shepherd Therapeutics
Sign Up For FreeTo access detailed company insights
Khora Therapeutics is focused on revolutionizing global access to next-generation oncology therapeutics through advanced precision medicine. The company aims to lead in the development of innovative cancer treatments. Their mission centers on providing groundbreaking therapies to patients in need. Khora Therapeutics targets healthcare providers and... Read More
